Kythera Files For IPO
socalTECH
MAY 17, 2012
Calabasas-based KYTHERA Biopharmaceuticals , a developer of biopharmaceuticals for the aesthetic medicine market, has filed for an IPO. The firm reported a net loss of $11.1M According to the firm's S-1 filing, Kythera is looking to raise up to $86.25M on the NASDAQ Global Market as KYTH. Morgan, Goldman, Sachs & Co.,
124 
Let's personalize your content